TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Aoxin Q&M Dental Group Ltd. ( (SG:1D4) ) is now available.
Aoxin Q&M Dental Group Ltd. announced that its two hospitals in China have identified an excess claim of approximately RMB3.7 million in material costs under the government medical co-payment scheme for FY2024, following a self-review mandated by the National Healthcare Security Administration. This refund is expected to materially impact the company’s financials in the first half of FY2025, and shareholders are advised to trade cautiously.
More about Aoxin Q&M Dental Group Ltd.
Aoxin Q&M Dental Group Ltd., incorporated in Singapore, operates in the healthcare industry, focusing on dental services. The company manages hospitals and clinics, providing dental treatments and related services, with a market focus on leveraging government medical co-payment schemes in China.
Average Trading Volume: 111,009
Technical Sentiment Signal: Sell
Current Market Cap: S$22.51M
For a thorough assessment of 1D4 stock, go to TipRanks’ Stock Analysis page.